Endokrynologiczne powikłania nowych terapii przeciwnowotworowych
DOI: https://doi.org/10.5604/01.3001.0014.8121 | Journal eISSN: 1732-2693
Language: English
Page range: 191 - 198
Submitted on: Mar 8, 2020
Accepted on: Nov 9, 2020
Published on: Mar 18, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2021 Michał Miner, Michał Elbaum, Aleksandra Jawiarczyk-Przybyłowska, Eliza Kubicka, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.